Global Heart Transplant Market

Heart Transplant Comprehensive Study by Demographics (Gender, -Male, -Female, -Unisex, Age, -0-10 Years, -11-29 Years, -30-49 Years, -50-69 Years, Others), End Users (Hospitals, Cardiac Institute, Others), Techniques (Orthotopic Heart Transplantation, Heterotopic Heart Transplantation) Players and Region - Global Market Outlook to 2028

Heart Transplant Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 9.6%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Heart Transplant
A Heart Transplant is an operation to replace a damaged or failing heart with a healthy heart from a donor who’s recently died. It may be recommended when a person’s life is at risk because their heart no longer works effectively. The advantage of heart transplantation is that it can save your life when you have no other options available. The increasing target disease incidence and growing geriatric population to drive heart transplant market.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
CAGR9.6%


Heart Transplant is highly competitive, with several key players dominating the industry. The market players are focused on developing a variety of features and benefits to meet the needs. Thus, constantly introducing new innovation in processing to meet the changing needs and preferences of consumers. The companies are also planning strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Heart Transplant market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Berlin Heart (Germany), ABIOMED (United States), MAQUET (Germany), Thoratec (United States), Teleflex (United States), HeartWare (United States), SynCardia (United States), CalonCardio (United Kingdom), Optum Inc. (United States) and CARMAT SA (France) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Apaxis Medical (United States), CryoLife (United Kingdom) and Others.

Segmentation Overview
AMA Research has segmented the market of Global Heart Transplant market by and Region.



On the basis of geography, the market of Heart Transplant has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Demographics, the sub-segment i.e. Gender will boost the Heart Transplant market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End Users, the sub-segment i.e. Hospitals will boost the Heart Transplant market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Techniques, the sub-segment i.e. Orthotopic Heart Transplantation will boost the Heart Transplant market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing number of patient suffering from cardiovascular disease. and Rising number of individuals with high blood cholesterol level.

Market Growth Drivers:
Increasing prevalence of coronary disease. and Increasing penetration and acceptance of cardiac assist devices in emerging countries

Challenges:
The increasing number of heart transplant candidate and limited donor supply has led to extended waiting list times.

Restraints:
The several potential risks and complications., Stringent eligibility criteria. and High cost of transplantation and post-operative care.

Opportunities:
Advancement of medical devices., Growing demand for minimally invasive CADs and Development of new therapies for heart failures.

Market Leaders and their expansionary development strategies
In December 2022, Johnson & Johnson, the world largest most diversified healthcare product company announced it has completed the acquisition of Abiomed Inc., Abiomed is part of Johnson & Johnson and operate as a standalone business within Johnson &Johnson’s MedTech segment to strengthen position.
In October 2023, Beth Israel Lahey Health (BILH) announced expanded its cardiovascular services to include heart transplantation, the first new program of its kind launched in New England in decades. Based at Beth Israel Deaconess Medical Centre (BIDMC) the program is led by a team of experienced surgeons, advanced heart failure physicians, cardiac anaesthesiologist, nurses, pharmacist, and support staff from across the BILH system with tremendous expertise in all aspects of heart transplantation.


Key Target Audience
Cardiac Institute, Potential Investors, Research and Development and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Demographics
  • Gender
  • -Male
  • -Female
  • -Unisex
  • Age
  • -0-10 Years
  • -11-29 Years
  • -30-49 Years
  • -50-69 Years
  • Others

By End Users
  • Hospitals
  • Cardiac Institute
  • Others

By Techniques
  • Orthotopic Heart Transplantation
  • Heterotopic Heart Transplantation

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing prevalence of coronary disease.
      • 3.2.2. Increasing penetration and acceptance of cardiac assist devices in emerging countries
    • 3.3. Market Challenges
      • 3.3.1. The increasing number of heart transplant candidate and limited donor supply has led to extended waiting list times.
    • 3.4. Market Trends
      • 3.4.1. Increasing number of patient suffering from cardiovascular disease.
      • 3.4.2. Rising number of individuals with high blood cholesterol level.
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Heart Transplant, by Demographics, End Users, Techniques and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Heart Transplant (Value)
      • 5.2.1. Global Heart Transplant by: Demographics (Value)
        • 5.2.1.1. Gender
        • 5.2.1.2. -Male
        • 5.2.1.3. -Female
        • 5.2.1.4. -Unisex
        • 5.2.1.5. Age
        • 5.2.1.6. -0-10 Years
        • 5.2.1.7. -11-29 Years
        • 5.2.1.8. -30-49 Years
        • 5.2.1.9. -50-69 Years
        • 5.2.1.10. Others
      • 5.2.2. Global Heart Transplant by: End Users (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Cardiac Institute
        • 5.2.2.3. Others
      • 5.2.3. Global Heart Transplant by: Techniques (Value)
        • 5.2.3.1. Orthotopic Heart Transplantation
        • 5.2.3.2. Heterotopic Heart Transplantation
      • 5.2.4. Global Heart Transplant Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Heart Transplant: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Berlin Heart (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. ABIOMED (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. MAQUET (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Thoratec (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Teleflex (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. HeartWare (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. SynCardia (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. CalonCardio (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Optum Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. CARMAT SA (France)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Heart Transplant Sale, by Demographics, End Users, Techniques and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Heart Transplant (Value)
      • 7.2.1. Global Heart Transplant by: Demographics (Value)
        • 7.2.1.1. Gender
        • 7.2.1.2. -Male
        • 7.2.1.3. -Female
        • 7.2.1.4. -Unisex
        • 7.2.1.5. Age
        • 7.2.1.6. -0-10 Years
        • 7.2.1.7. -11-29 Years
        • 7.2.1.8. -30-49 Years
        • 7.2.1.9. -50-69 Years
        • 7.2.1.10. Others
      • 7.2.2. Global Heart Transplant by: End Users (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Cardiac Institute
        • 7.2.2.3. Others
      • 7.2.3. Global Heart Transplant by: Techniques (Value)
        • 7.2.3.1. Orthotopic Heart Transplantation
        • 7.2.3.2. Heterotopic Heart Transplantation
      • 7.2.4. Global Heart Transplant Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Heart Transplant: by Demographics(USD Million)
  • Table 2. Heart Transplant Gender , by Region USD Million (2017-2022)
  • Table 3. Heart Transplant -Male , by Region USD Million (2017-2022)
  • Table 4. Heart Transplant -Female , by Region USD Million (2017-2022)
  • Table 5. Heart Transplant -Unisex , by Region USD Million (2017-2022)
  • Table 6. Heart Transplant Age , by Region USD Million (2017-2022)
  • Table 7. Heart Transplant -0-10 Years , by Region USD Million (2017-2022)
  • Table 8. Heart Transplant -11-29 Years , by Region USD Million (2017-2022)
  • Table 9. Heart Transplant -30-49 Years , by Region USD Million (2017-2022)
  • Table 10. Heart Transplant -50-69 Years , by Region USD Million (2017-2022)
  • Table 11. Heart Transplant Others , by Region USD Million (2017-2022)
  • Table 12. Heart Transplant: by End Users(USD Million)
  • Table 13. Heart Transplant Hospitals , by Region USD Million (2017-2022)
  • Table 14. Heart Transplant Cardiac Institute , by Region USD Million (2017-2022)
  • Table 15. Heart Transplant Others , by Region USD Million (2017-2022)
  • Table 16. Heart Transplant: by Techniques(USD Million)
  • Table 17. Heart Transplant Orthotopic Heart Transplantation , by Region USD Million (2017-2022)
  • Table 18. Heart Transplant Heterotopic Heart Transplantation , by Region USD Million (2017-2022)
  • Table 19. South America Heart Transplant, by Country USD Million (2017-2022)
  • Table 20. South America Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 21. South America Heart Transplant, by End Users USD Million (2017-2022)
  • Table 22. South America Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 23. Brazil Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 24. Brazil Heart Transplant, by End Users USD Million (2017-2022)
  • Table 25. Brazil Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 26. Argentina Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 27. Argentina Heart Transplant, by End Users USD Million (2017-2022)
  • Table 28. Argentina Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 29. Rest of South America Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 30. Rest of South America Heart Transplant, by End Users USD Million (2017-2022)
  • Table 31. Rest of South America Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 32. Asia Pacific Heart Transplant, by Country USD Million (2017-2022)
  • Table 33. Asia Pacific Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 34. Asia Pacific Heart Transplant, by End Users USD Million (2017-2022)
  • Table 35. Asia Pacific Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 36. China Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 37. China Heart Transplant, by End Users USD Million (2017-2022)
  • Table 38. China Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 39. Japan Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 40. Japan Heart Transplant, by End Users USD Million (2017-2022)
  • Table 41. Japan Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 42. India Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 43. India Heart Transplant, by End Users USD Million (2017-2022)
  • Table 44. India Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 45. South Korea Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 46. South Korea Heart Transplant, by End Users USD Million (2017-2022)
  • Table 47. South Korea Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 48. Taiwan Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 49. Taiwan Heart Transplant, by End Users USD Million (2017-2022)
  • Table 50. Taiwan Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 51. Australia Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 52. Australia Heart Transplant, by End Users USD Million (2017-2022)
  • Table 53. Australia Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 54. Rest of Asia-Pacific Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 55. Rest of Asia-Pacific Heart Transplant, by End Users USD Million (2017-2022)
  • Table 56. Rest of Asia-Pacific Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 57. Europe Heart Transplant, by Country USD Million (2017-2022)
  • Table 58. Europe Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 59. Europe Heart Transplant, by End Users USD Million (2017-2022)
  • Table 60. Europe Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 61. Germany Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 62. Germany Heart Transplant, by End Users USD Million (2017-2022)
  • Table 63. Germany Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 64. France Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 65. France Heart Transplant, by End Users USD Million (2017-2022)
  • Table 66. France Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 67. Italy Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 68. Italy Heart Transplant, by End Users USD Million (2017-2022)
  • Table 69. Italy Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 70. United Kingdom Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 71. United Kingdom Heart Transplant, by End Users USD Million (2017-2022)
  • Table 72. United Kingdom Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 73. Netherlands Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 74. Netherlands Heart Transplant, by End Users USD Million (2017-2022)
  • Table 75. Netherlands Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 76. Rest of Europe Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 77. Rest of Europe Heart Transplant, by End Users USD Million (2017-2022)
  • Table 78. Rest of Europe Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 79. MEA Heart Transplant, by Country USD Million (2017-2022)
  • Table 80. MEA Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 81. MEA Heart Transplant, by End Users USD Million (2017-2022)
  • Table 82. MEA Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 83. Middle East Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 84. Middle East Heart Transplant, by End Users USD Million (2017-2022)
  • Table 85. Middle East Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 86. Africa Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 87. Africa Heart Transplant, by End Users USD Million (2017-2022)
  • Table 88. Africa Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 89. North America Heart Transplant, by Country USD Million (2017-2022)
  • Table 90. North America Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 91. North America Heart Transplant, by End Users USD Million (2017-2022)
  • Table 92. North America Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 93. United States Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 94. United States Heart Transplant, by End Users USD Million (2017-2022)
  • Table 95. United States Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 96. Canada Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 97. Canada Heart Transplant, by End Users USD Million (2017-2022)
  • Table 98. Canada Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 99. Mexico Heart Transplant, by Demographics USD Million (2017-2022)
  • Table 100. Mexico Heart Transplant, by End Users USD Million (2017-2022)
  • Table 101. Mexico Heart Transplant, by Techniques USD Million (2017-2022)
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Heart Transplant: by Demographics(USD Million)
  • Table 113. Heart Transplant Gender , by Region USD Million (2023-2028)
  • Table 114. Heart Transplant -Male , by Region USD Million (2023-2028)
  • Table 115. Heart Transplant -Female , by Region USD Million (2023-2028)
  • Table 116. Heart Transplant -Unisex , by Region USD Million (2023-2028)
  • Table 117. Heart Transplant Age , by Region USD Million (2023-2028)
  • Table 118. Heart Transplant -0-10 Years , by Region USD Million (2023-2028)
  • Table 119. Heart Transplant -11-29 Years , by Region USD Million (2023-2028)
  • Table 120. Heart Transplant -30-49 Years , by Region USD Million (2023-2028)
  • Table 121. Heart Transplant -50-69 Years , by Region USD Million (2023-2028)
  • Table 122. Heart Transplant Others , by Region USD Million (2023-2028)
  • Table 123. Heart Transplant: by End Users(USD Million)
  • Table 124. Heart Transplant Hospitals , by Region USD Million (2023-2028)
  • Table 125. Heart Transplant Cardiac Institute , by Region USD Million (2023-2028)
  • Table 126. Heart Transplant Others , by Region USD Million (2023-2028)
  • Table 127. Heart Transplant: by Techniques(USD Million)
  • Table 128. Heart Transplant Orthotopic Heart Transplantation , by Region USD Million (2023-2028)
  • Table 129. Heart Transplant Heterotopic Heart Transplantation , by Region USD Million (2023-2028)
  • Table 130. South America Heart Transplant, by Country USD Million (2023-2028)
  • Table 131. South America Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 132. South America Heart Transplant, by End Users USD Million (2023-2028)
  • Table 133. South America Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 134. Brazil Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 135. Brazil Heart Transplant, by End Users USD Million (2023-2028)
  • Table 136. Brazil Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 137. Argentina Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 138. Argentina Heart Transplant, by End Users USD Million (2023-2028)
  • Table 139. Argentina Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 140. Rest of South America Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 141. Rest of South America Heart Transplant, by End Users USD Million (2023-2028)
  • Table 142. Rest of South America Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 143. Asia Pacific Heart Transplant, by Country USD Million (2023-2028)
  • Table 144. Asia Pacific Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 145. Asia Pacific Heart Transplant, by End Users USD Million (2023-2028)
  • Table 146. Asia Pacific Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 147. China Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 148. China Heart Transplant, by End Users USD Million (2023-2028)
  • Table 149. China Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 150. Japan Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 151. Japan Heart Transplant, by End Users USD Million (2023-2028)
  • Table 152. Japan Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 153. India Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 154. India Heart Transplant, by End Users USD Million (2023-2028)
  • Table 155. India Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 156. South Korea Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 157. South Korea Heart Transplant, by End Users USD Million (2023-2028)
  • Table 158. South Korea Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 159. Taiwan Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 160. Taiwan Heart Transplant, by End Users USD Million (2023-2028)
  • Table 161. Taiwan Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 162. Australia Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 163. Australia Heart Transplant, by End Users USD Million (2023-2028)
  • Table 164. Australia Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 165. Rest of Asia-Pacific Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 166. Rest of Asia-Pacific Heart Transplant, by End Users USD Million (2023-2028)
  • Table 167. Rest of Asia-Pacific Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 168. Europe Heart Transplant, by Country USD Million (2023-2028)
  • Table 169. Europe Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 170. Europe Heart Transplant, by End Users USD Million (2023-2028)
  • Table 171. Europe Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 172. Germany Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 173. Germany Heart Transplant, by End Users USD Million (2023-2028)
  • Table 174. Germany Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 175. France Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 176. France Heart Transplant, by End Users USD Million (2023-2028)
  • Table 177. France Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 178. Italy Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 179. Italy Heart Transplant, by End Users USD Million (2023-2028)
  • Table 180. Italy Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 181. United Kingdom Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 182. United Kingdom Heart Transplant, by End Users USD Million (2023-2028)
  • Table 183. United Kingdom Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 184. Netherlands Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 185. Netherlands Heart Transplant, by End Users USD Million (2023-2028)
  • Table 186. Netherlands Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 187. Rest of Europe Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 188. Rest of Europe Heart Transplant, by End Users USD Million (2023-2028)
  • Table 189. Rest of Europe Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 190. MEA Heart Transplant, by Country USD Million (2023-2028)
  • Table 191. MEA Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 192. MEA Heart Transplant, by End Users USD Million (2023-2028)
  • Table 193. MEA Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 194. Middle East Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 195. Middle East Heart Transplant, by End Users USD Million (2023-2028)
  • Table 196. Middle East Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 197. Africa Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 198. Africa Heart Transplant, by End Users USD Million (2023-2028)
  • Table 199. Africa Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 200. North America Heart Transplant, by Country USD Million (2023-2028)
  • Table 201. North America Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 202. North America Heart Transplant, by End Users USD Million (2023-2028)
  • Table 203. North America Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 204. United States Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 205. United States Heart Transplant, by End Users USD Million (2023-2028)
  • Table 206. United States Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 207. Canada Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 208. Canada Heart Transplant, by End Users USD Million (2023-2028)
  • Table 209. Canada Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 210. Mexico Heart Transplant, by Demographics USD Million (2023-2028)
  • Table 211. Mexico Heart Transplant, by End Users USD Million (2023-2028)
  • Table 212. Mexico Heart Transplant, by Techniques USD Million (2023-2028)
  • Table 213. Research Programs/Design for This Report
  • Table 214. Key Data Information from Secondary Sources
  • Table 215. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Heart Transplant: by Demographics USD Million (2017-2022)
  • Figure 5. Global Heart Transplant: by End Users USD Million (2017-2022)
  • Figure 6. Global Heart Transplant: by Techniques USD Million (2017-2022)
  • Figure 7. South America Heart Transplant Share (%), by Country
  • Figure 8. Asia Pacific Heart Transplant Share (%), by Country
  • Figure 9. Europe Heart Transplant Share (%), by Country
  • Figure 10. MEA Heart Transplant Share (%), by Country
  • Figure 11. North America Heart Transplant Share (%), by Country
  • Figure 12. Global Heart Transplant share by Players 2022 (%)
  • Figure 13. Global Heart Transplant share by Players (Top 3) 2022(%)
  • Figure 14. Global Heart Transplant share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Berlin Heart (Germany) Revenue, Net Income and Gross profit
  • Figure 17. Berlin Heart (Germany) Revenue: by Geography 2022
  • Figure 18. ABIOMED (United States) Revenue, Net Income and Gross profit
  • Figure 19. ABIOMED (United States) Revenue: by Geography 2022
  • Figure 20. MAQUET (Germany) Revenue, Net Income and Gross profit
  • Figure 21. MAQUET (Germany) Revenue: by Geography 2022
  • Figure 22. Thoratec (United States) Revenue, Net Income and Gross profit
  • Figure 23. Thoratec (United States) Revenue: by Geography 2022
  • Figure 24. Teleflex (United States) Revenue, Net Income and Gross profit
  • Figure 25. Teleflex (United States) Revenue: by Geography 2022
  • Figure 26. HeartWare (United States) Revenue, Net Income and Gross profit
  • Figure 27. HeartWare (United States) Revenue: by Geography 2022
  • Figure 28. SynCardia (United States) Revenue, Net Income and Gross profit
  • Figure 29. SynCardia (United States) Revenue: by Geography 2022
  • Figure 30. CalonCardio (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 31. CalonCardio (United Kingdom) Revenue: by Geography 2022
  • Figure 32. Optum Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Optum Inc. (United States) Revenue: by Geography 2022
  • Figure 34. CARMAT SA (France) Revenue, Net Income and Gross profit
  • Figure 35. CARMAT SA (France) Revenue: by Geography 2022
  • Figure 36. Global Heart Transplant: by Demographics USD Million (2023-2028)
  • Figure 37. Global Heart Transplant: by End Users USD Million (2023-2028)
  • Figure 38. Global Heart Transplant: by Techniques USD Million (2023-2028)
  • Figure 39. South America Heart Transplant Share (%), by Country
  • Figure 40. Asia Pacific Heart Transplant Share (%), by Country
  • Figure 41. Europe Heart Transplant Share (%), by Country
  • Figure 42. MEA Heart Transplant Share (%), by Country
  • Figure 43. North America Heart Transplant Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Berlin Heart (Germany)
  • ABIOMED (United States)
  • MAQUET (Germany)
  • Thoratec (United States)
  • Teleflex (United States)
  • HeartWare (United States)
  • SynCardia (United States)
  • CalonCardio (United Kingdom)
  • Optum Inc. (United States)
  • CARMAT SA (France)
Additional players considered in the study are as follows:
Apaxis Medical (United States) , CryoLife (United Kingdom) , Others
Select User Access Type

Key Highlights of Report


Jan 2024 220 Pages 91 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Heart Transplant Market Quantitative research analysis
Global Heart Transplant Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Berlin Heart (Germany), ABIOMED (United States), MAQUET (Germany), Thoratec (United States), Teleflex (United States), HeartWare (United States), SynCardia (United States), CalonCardio (United Kingdom), Optum Inc. (United States) and CARMAT SA (France) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing number of patient suffering from cardiovascular disease. " is seen as one of major influencing trends for Heart Transplant Market during projected period 2022-2028.
The Heart Transplant market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.
Analysts at AMA estimates Heart Transplant Market to reach USD24300.0 Million by 2028.

Know More About Global Heart Transplant Market Report?

Have a Query? Click Here

Other Related Reports

Systemic Psoriasis Therapeutic Comprehensive Study by Type (Plaque Psoriasis, Psoriatic Arthritis, Others), Route of Administration (Oral, Parenteral/Systemic, Topical), Distribution Channel (Direct,...
$ 3800
Systemic Lupus Erythematosus Treatment Comprehensive Study by Type (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Antimalarial Drugs, Corticosteroids, Immunosuppressants, Biologics, Others), End use...
$ 3800
Human Papillomavirus Therapeutics Comprehensive Study by Route of Administration (Parenteral, Topical), Vaccine Type (Peptide-based Vaccines, Protein-based Vaccines, Viral-vectored vaccines, Bacteria...
$ 3800
Neuropsychiatric Disorders And Treatment Comprehensive Study by Types (Degenerative Diseases, Psychosis, Neurotic Disorder), End Users (Hospitals, Specialty Clinics, Research & Development Centers, A...
$ 3800
Sepsis and Septic Shock Comprehensive Study by Type (Automated Diagnostics, Conventional Diagnostics), By End User (Hospitals, Pathology Center, Laboratories, Research Organization, Others), By Techn...
$ 3800
Upper-limb Robotic Neurorehabilitation Comprehensive Study by Type (Exoskeletons, End-effector Devices, Robotic Arms, Electrical Stimulation Devices, VR Systems, Others), By End User (Hospitals & Cli...
$ 3800